| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| hypoxia-inducible factor 1 alpha subunit | 9 | 0 | 0 | 9 |
| RAR-related orphan receptor gamma | 20 | 0 | 0 | 20 |
| GLI family zinc finger 3 | 20 | 0 | 0 | 20 |
| AR protein | 30 | 0 | 0 | 30 |
| aldehyde dehydrogenase 1 family, member A1 | 8 | 0 | 0 | 8 |
| retinoic acid nuclear receptor alpha variant 1 | 18 | 0 | 0 | 18 |
| retinoid X nuclear receptor alpha | 16 | 0 | 0 | 16 |
| estrogen nuclear receptor alpha | 28 | 0 | 0 | 28 |
| peroxisome proliferator-activated receptor delta | 11 | 0 | 0 | 11 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 19 | 0 | 0 | 19 |
| activating transcription factor 6 | 9 | 0 | 0 | 9 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 9 | 0 | 0 | 9 |
| Histone H2A.x | 12 | 0 | 0 | 12 |
| thyroid hormone receptor beta isoform a | 7 | 0 | 0 | 7 |
| heat shock protein beta-1 | 8 | 0 | 0 | 8 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 16 | 0 | 0 | 16 |
| lamin isoform A-delta10 | 17 | 0 | 0 | 17 |
| Voltage-dependent calcium channel gamma-2 subunit | 12 | 0 | 0 | 12 |
| Glutamate receptor 2 | 13 | 0 | 0 | 13 |
| Chain E, Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 5 | 0 | 0 | 5 |
| Chain A, Ferritin light chain | 7 | 0 | 0 | 7 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| thioredoxin reductase | 9 | 0 | 0 | 9 |
| phosphopantetheinyl transferase | 6 | 0 | 0 | 6 |
| GLS protein | 7 | 0 | 0 | 7 |
| TDP1 protein | 19 | 0 | 0 | 19 |
| Smad3 | 4 | 0 | 0 | 4 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| EWS/FLI fusion protein | 11 | 0 | 0 | 12 |
| arylsulfatase A | 3 | 0 | 0 | 3 |
| euchromatic histone-lysine N-methyltransferase 2 | 13 | 0 | 0 | 13 |
| Bloom syndrome protein isoform 1 | 6 | 0 | 0 | 6 |
| hemoglobin subunit beta | 2 | 0 | 0 | 2 |
| atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 5 |
| ATP-binding cassette sub-family C member 3 | 0 | 10 | 0 | 10 |
| Multidrug resistance-associated protein 4 | 0 | 10 | 0 | 11 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Bile salt export pump | 0 | 13 | 0 | 13 |
| Purine nucleoside phosphorylase | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 0 | 0 | 1 |
| POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
| Cytochrome P450 2C9 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2J2 | 0 | 3 | 0 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 2 | 0 | 0 | 2 |
| Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 2 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 2 |
| Canalicular multispecific organic anion transporter 1 | 0 | 10 | 0 | 10 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 9 | 0 | 0 | 9 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 4 | 0 | 0 | 4 |
| Chain A, 2-oxoglutarate Oxygenase | 5 | 0 | 0 | 5 |
| Luciferase | 8 | 0 | 0 | 8 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| 15-lipoxygenase, partial | 4 | 0 | 0 | 4 |
| WRN | 1 | 0 | 0 | 1 |
| USP1 protein, partial | 8 | 0 | 0 | 8 |
| Microtubule-associated protein tau | 5 | 0 | 0 | 6 |
| estrogen receptor 2 (ER beta) | 9 | 0 | 0 | 9 |
| nuclear receptor subfamily 1, group I, member 3 | 14 | 0 | 0 | 14 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 11 | 0 | 0 | 11 |
| G | 6 | 0 | 0 | 6 |
| cytochrome P450 2D6 | 7 | 0 | 0 | 7 |
| peroxisome proliferator activated receptor gamma | 12 | 0 | 0 | 12 |
| aryl hydrocarbon receptor | 9 | 0 | 0 | 9 |
| thyroid stimulating hormone receptor | 10 | 0 | 0 | 10 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 4 | 0 | 0 | 4 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 4 | 0 | 0 | 4 |
| chromobox protein homolog 1 | 9 | 0 | 0 | 9 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 8 | 0 | 0 | 9 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 4 | 0 | 0 | 4 |
| histone deacetylase 9 isoform 3 | 4 | 0 | 0 | 4 |
| importin subunit beta-1 isoform 1 | 4 | 0 | 0 | 4 |
| mitogen-activated protein kinase 1 | 6 | 0 | 0 | 6 |
| flap endonuclease 1 | 6 | 0 | 0 | 6 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 4 | 0 | 0 | 4 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 5 | 0 | 0 | 5 |
| tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 3 | 0 | 0 | 3 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 0 | 1 |
| geminin | 15 | 0 | 0 | 15 |
| DNA polymerase kappa isoform 1 | 7 | 0 | 0 | 7 |
| Vpr | 2 | 0 | 0 | 2 |
| survival motor neuron protein isoform d | 3 | 0 | 0 | 3 |
| cytochrome P450 3A4 isoform 1 | 8 | 0 | 0 | 8 |
| histone acetyltransferase KAT2A isoform 1 | 6 | 0 | 0 | 6 |
| kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit pi | 8 | 0 | 0 | 8 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 3 | 0 | 0 | 3 |
| Interferon beta | 12 | 0 | 0 | 12 |
| HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
| Transthyretin | 0 | 1 | 0 | 1 |
| Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
| Cellular tumor antigen p53 | 18 | 0 | 0 | 18 |
| Apoptosis regulator Bcl-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit delta | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 8 | 0 | 0 | 8 |
| D(3) dopamine receptor | 0 | 1 | 0 | 1 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 8 | 0 | 0 | 8 |
| Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 8 | 0 | 0 | 8 |
| Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 8 | 0 | 0 | 8 |
| Histamine H2 receptor | 4 | 0 | 0 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 8 | 0 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 8 | 0 | 0 | 8 |
| Guanine nucleotide-binding protein G | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 8 | 0 | 0 | 8 |
| Inositol monophosphatase 1 | 3 | 0 | 0 | 3 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 1 | 0 | 1 |
| TAR DNA-binding protein 43 | 8 | 0 | 0 | 8 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| RmtA | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 1 | 0 | 2 |
| GABA theta subunit | 8 | 0 | 0 | 8 |
| Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
| Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 8 | 0 | 0 | 8 |
| cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
| phosphoglycerate kinase | 2 | 0 | 0 | 2 |
| acetylcholinesterase | 7 | 0 | 0 | 7 |
| NFKB1 protein, partial | 3 | 0 | 0 | 3 |
| signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 6 | 0 | 0 | 6 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform 2 | 17 | 0 | 0 | 17 |
| peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
| Matrix protein 2 | 0 | 1 | 1 | 2 |
| Matrix protein 2 | 0 | 1 | 2 | 3 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 1 | 6 |
| Spike glycoprotein | 10 | 0 | 0 | 10 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 1 | 5 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 1 | 5 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 1 | 5 |
| Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 1 | 5 |
| ATP-dependent phosphofructokinase | 6 | 0 | 0 | 6 |
| Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| glucocorticoid receptor [Homo sapiens] | 19 | 0 | 0 | 19 |
| estrogen-related nuclear receptor alpha | 18 | 0 | 0 | 18 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 11 | 0 | 0 | 11 |
| IDH1 | 9 | 0 | 0 | 9 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 3 | 0 | 0 | 3 |
| lethal factor (plasmid) | 6 | 0 | 0 | 6 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Urease | 0 | 1 | 0 | 1 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 3 | 1 | 4 |
| Hyaluronate lyase | 0 | 1 | 0 | 1 |
| Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
| Egl nine homolog 1 | 0 | 1 | 1 | 3 |
| Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
| Hypoxia-inducible factor 1-alpha inhibitor | 0 | 1 | 0 | 2 |
| Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
| pregnane X nuclear receptor | 11 | 0 | 0 | 11 |
| cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 3 | 0 | 0 | 3 |
| short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M2 | 0 | 5 | 2 | 10 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 7 |
| Muscarinic acetylcholine receptor M1 | 0 | 4 | 1 | 8 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 8 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 8 |
| Muscarinic acetylcholine receptor M5 | 0 | 4 | 1 | 8 |
| Muscarinic acetylcholine receptor M5 | 0 | 5 | 1 | 8 |
| Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 9 |
| Muscarinic acetylcholine receptor M1 | 0 | 5 | 3 | 11 |
| Muscarinic acetylcholine receptor M1 | 0 | 0 | 1 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 7 |
| Alpha-1D adrenergic receptor | 0 | 6 | 1 | 7 |
| 5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
| Cytochrome P450 3A4 | 0 | 5 | 0 | 5 |
| Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
| Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 3 | 0 | 3 |
| Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
| caspase 7, apoptosis-related cysteine protease | 6 | 0 | 0 | 6 |
| caspase-3 | 6 | 0 | 0 | 6 |
| ATPase family AAA domain-containing protein 5 | 11 | 0 | 0 | 11 |
| Ataxin-2 | 11 | 0 | 0 | 11 |
| Pannexin-1 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 4 | 0 | 0 | 4 |
| Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
| Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 2 | 0 | 1 | 1 | 2 |
| Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
| progesterone receptor | 13 | 0 | 0 | 13 |
| nuclear receptor subfamily 1, group I, member 2 | 11 | 0 | 0 | 11 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 6 | 0 | 0 | 6 |
| Chain A, Breast cancer type 1 susceptibility protein | 2 | 0 | 0 | 2 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 3 | 0 | 0 | 3 |
| Chain A, Cruzipain | 3 | 0 | 0 | 3 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| Nrf2 | 1 | 0 | 0 | 1 |
| pregnane X receptor | 2 | 0 | 0 | 2 |
| SMAD family member 2 | 7 | 0 | 0 | 7 |
| ATAD5 protein, partial | 5 | 0 | 0 | 5 |
| SMAD family member 3 | 7 | 0 | 0 | 7 |
| alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 7 | 0 | 0 | 7 |
| PINK1 | 2 | 0 | 0 | 2 |
| farnesoid X nuclear receptor | 8 | 0 | 0 | 8 |
| glucocerebrosidase | 2 | 0 | 0 | 2 |
| Parkin | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 3 | 0 | 0 | 3 |
| toll-like receptor 9 | 0 | 1 | 0 | 1 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2 | 0 | 0 | 2 |
| TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 4 | 0 | 0 | 4 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
| lysosomal alpha-glucosidase preproprotein | 2 | 0 | 0 | 2 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 7 | 0 | 0 | 7 |
| intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| huntingtin isoform 2 | 3 | 0 | 0 | 3 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 3 | 0 | 0 | 3 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 2 | 0 | 0 | 2 |
| urokinase-type plasminogen activator precursor | 4 | 0 | 0 | 4 |
| plasminogen precursor | 4 | 0 | 0 | 4 |
| urokinase plasminogen activator surface receptor precursor | 4 | 0 | 0 | 4 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| muscleblind-like protein 1 isoform 1 | 3 | 0 | 0 | 3 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 0 | 0 | 2 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
| caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
| hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 2 | 0 | 0 | 2 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Phospholipase A2 | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 2 | 0 | 2 |
| Amyloid-beta precursor protein | 0 | 1 | 0 | 2 |
| Integrin beta-3 | 3 | 0 | 0 | 3 |
| Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 3 | 0 | 0 | 3 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Replicase polyprotein 1ab | 0 | 2 | 1 | 3 |
| Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 1 | 0 | 1 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 5 | 0 | 5 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 2 | 0 | 2 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 2 | 1 | 1 | 4 |
| Alpha-1A adrenergic receptor | 0 | 6 | 0 | 6 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Caspase-7 | 3 | 0 | 0 | 3 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Beta-secretase 1 | 0 | 1 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 4 | 0 | 4 |
| Cholinesterase | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
| Sodium/bile acid cotransporter | 0 | 0 | 1 | 1 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 1 |
| Thiosulfate sulfurtransferase | 0 | 4 | 0 | 4 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 4 | 0 | 4 |
| 10 kDa chaperonin | 0 | 4 | 0 | 4 |
| Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
| Sortase A | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 2 | 0 | 2 |
| CREB-binding protein | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
| Cysteine protease | 0 | 1 | 0 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 2 | 0 | 2 |
| Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 1 | 0 | 2 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
| Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
| Glucose transporter | 0 | 1 | 0 | 1 |
| Cdk-related protein kinase 6 | 0 | 1 | 0 | 1 |
| Protein kinase domain-containing protein | 0 | 1 | 0 | 1 |
| Hexose transporter 1 | 0 | 1 | 0 | 1 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| Cytidine deaminase | 0 | 0 | 0 | 1 |
| Calcium-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase | 0 | 1 | 0 | 1 |
| Proline--tRNA ligase | 0 | 1 | 0 | 1 |
| Calcium-dependent protein kinase 4 | 0 | 1 | 0 | 1 |
| Lysine--tRNA ligase | 0 | 1 | 0 | 1 |
| Uridine-cytidine kinase 1 | 0 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
| Genome polyprotein | 0 | 1 | 1 | 2 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| Fumarate hydratase | 2 | 0 | 0 | 2 |
| hypothetical protein, conserved | 3 | 0 | 0 | 3 |
| polyprotein | 2 | 0 | 0 | 2 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
| large T antigen | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor alpha | 0 | 0 | 1 | 1 |
| Thyroid hormone receptor beta | 0 | 0 | 1 | 1 |
| Prolyl 4-hydroxylase | 0 | 2 | 0 | 2 |
| Prolyl 3-hydroxylase OGFOD1 | 0 | 1 | 0 | 1 |
| Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 2 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Glucocorticoid receptor | 0 | 6 | 1 | 12 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 0 | 0 | 1 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 0 | 0 | 1 |
| Androgen receptor | 0 | 5 | 0 | 5 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
| alpha synuclein, partial | 1 | 0 | 0 | 1 |
| 67.9K protein | 3 | 0 | 0 | 3 |
| luciferase | 1 | 0 | 0 | 1 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| tumor necrosis factor | 2 | 0 | 0 | 2 |
| caspase-3 | 2 | 0 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Fyn | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 5 | 1 | 6 |
| Adenosine receptor A3 | 0 | 2 | 0 | 2 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 3 | 0 | 3 |
| Alpha-2C adrenergic receptor | 0 | 4 | 1 | 5 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 1 | 1 | 0 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| D(3) dopamine receptor | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, kainate 2 | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 3 | 1 | 0 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 4 | 1 | 0 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Leukotriene B4 receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, kainate 5 | 1 | 0 | 0 | 1 |
| Leukotriene B4 receptor 2 | 1 | 0 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 3 | 0 | 3 |
| Rho-associated protein kinase 1 | 0 | 3 | 0 | 3 |
| Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 1 | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Serine racemase | 0 | 1 | 0 | 1 |
| Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
| Sodium- and chloride-dependent glycine transporter 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 1 | 0 | 1 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 4 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 5 |
| Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
| Sodium channel protein type 9 subunit alpha | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily D member 2 | 0 | 1 | 0 | 1 |
| Potassium channel subfamily K member 18 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| PPM1D protein | 3 | 0 | 0 | 3 |
| retinoic acid receptor alpha isoform 1 | 0 | 1 | 0 | 1 |
| retinoic acid receptor RXR-alpha isoform a | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 3 | 0 | 4 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| ClpP | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| alpha-galactosidase | 1 | 0 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| M-phase phosphoprotein 8 | 1 | 0 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 2 | 0 | 2 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
| glp-1 receptor, partial | 4 | 0 | 0 | 4 |
| Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
| D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| Beta-2 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
| Beta-3 adrenergic receptor | 0 | 0 | 1 | 1 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 3 | 1 | 4 |
| Alpha-2C adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2A adrenergic receptor | 0 | 2 | 1 | 3 |
| Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 3 | 3 | 6 |
| Alpha-1B adrenergic receptor | 0 | 3 | 3 | 6 |
| Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 1 | 2 |
| Muscarinic acetylcholine receptor DM1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| Glutamate 5-kinase | 0 | 0 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Chain A, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain B, 6,7-Dimethyl-8-ribityllumazine Synthase | 0 | 0 | 1 | 1 |
| Chain H, Immunoglobulin Igg1 Heavy chain | 0 | 0 | 1 | 1 |
| Chain L, Immunoglobulin Igg1 Lambda Light Chain | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain A, DODECIN | 0 | 0 | 1 | 1 |
| Chain C, DODECIN | 0 | 0 | 1 | 1 |
| Chain E, DODECIN | 0 | 0 | 1 | 1 |
| NPYLR7B | 0 | 0 | 1 | 1 |
| Riboflavin-binding protein | 0 | 1 | 1 | 2 |
| photoreceptor-specific nuclear receptor | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Insulin receptor | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
| isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
| nonstructural protein 1 | 0 | 1 | 0 | 1 |
| protein AF-9 isoform a | 0 | 0 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
| Transporter | 0 | 1 | 0 | 1 |
| Sterol 14-alpha-demethylase | 0 | 0 | 1 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
| Cytochrome P450 144 | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
| Sterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| Cholesterol 24-hydroxylase | 0 | 2 | 1 | 3 |
| Chain E, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain I, cAMP-dependent protein kinase inhibitor, alpha form | 0 | 1 | 0 | 1 |
| Chain B, Rho-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Chain A, Rho-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Chain A, Rho-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain I, cAMP-dependent protein kinase inhibitor alpha | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain A, cAMP-dependent protein kinase, alpha-catalytic subunit | 0 | 1 | 0 | 1 |
| Chain I, cAMP-dependent protein kinase inhibitor alpha | 0 | 1 | 0 | 1 |
| Chain A, Rho-associated protein kinase 1 | 0 | 1 | 0 | 1 |
| Ribosomal protein S6 kinase alpha-5 | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| C-C motif chemokine 2 | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit gamma | 0 | 1 | 0 | 1 |
| cAMP-dependent protein kinase catalytic subunit beta | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase N2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 1 | 1 |
| twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
| 30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
| 30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
| 50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |